- Home
- STHO vs ANEB Comparison
STHO vs ANEB Comparison
Compare STHO & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- ANEB
- Stock Information
- Founded
- STHO N/A
- ANEB 2020
- Country
- STHO United States
- ANEB United States
- Employees
- STHO N/A
- ANEB N/A
- Industry
- STHO Real Estate
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- STHO Real Estate
- ANEB Health Care
- Exchange
- STHO Nasdaq
- ANEB Nasdaq
- Market Cap
- STHO 113.4M
- ANEB 102.7M
- IPO Year
- STHO N/A
- ANEB 2021
- Fundamental
- Price
- STHO $8.74
- ANEB $2.20
- Analyst Decision
- STHO
- ANEB Buy
- Analyst Count
- STHO 0
- ANEB 2
- Target Price
- STHO N/A
- ANEB $8.00
- AVG Volume (30 Days)
- STHO 50.2K
- ANEB 81.2K
- Earning Date
- STHO 11-04-2025
- ANEB 09-24-2025
- Dividend Yield
- STHO N/A
- ANEB N/A
- EPS Growth
- STHO N/A
- ANEB N/A
- EPS
- STHO N/A
- ANEB N/A
- Revenue
- STHO $113,989,000.00
- ANEB N/A
- Revenue This Year
- STHO N/A
- ANEB N/A
- Revenue Next Year
- STHO N/A
- ANEB N/A
- P/E Ratio
- STHO N/A
- ANEB N/A
- Revenue Growth
- STHO N/A
- ANEB N/A
- 52 Week Low
- STHO $6.06
- ANEB $0.80
- 52 Week High
- STHO $14.50
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- STHO 68.36
- ANEB 39.36
- Support Level
- STHO $8.39
- ANEB $2.35
- Resistance Level
- STHO $8.77
- ANEB $2.90
- Average True Range (ATR)
- STHO 0.25
- ANEB 0.17
- MACD
- STHO 0.03
- ANEB -0.06
- Stochastic Oscillator
- STHO 85.53
- ANEB 14.63
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.